These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10933597)

  • 21. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
    Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
    J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB; Lester T; Levinsky RJ; Kinnon C
    Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function.
    Rawlings DJ; Witte ON
    Semin Immunol; 1995 Aug; 7(4):237-46. PubMed ID: 8520028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
    Hagemann TL; Rosen FS; Kwan SP
    Hum Mutat; 1995; 5(4):296-302. PubMed ID: 7627183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of patients with defects in early B-cell development.
    Conley ME; Broides A; Hernandez-Trujillo V; Howard V; Kanegane H; Miyawaki T; Shurtleff SA
    Immunol Rev; 2005 Feb; 203():216-34. PubMed ID: 15661032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Bruton's tyrosine kinase in B cell development.
    Maas A; Hendriks RW
    Dev Immunol; 2001; 8(3-4):171-81. PubMed ID: 11785667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia.
    Vorechovský I; Luo L; Hertz JM; Frøland SS; Klemola T; Fiorini M; Quinti I; Paganelli R; Ozsahin H; Hammarström L; Webster AD; Smith CI
    Hum Mutat; 1997; 9(5):418-25. PubMed ID: 9143921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.
    Yip KL; Chan SY; Ip WK; Lau YL
    Hum Mutat; 2000 Apr; 15(4):385. PubMed ID: 10737994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Bruton's tyrosine kinase protein within the B cell lineage.
    Genevier HC; Hinshelwood S; Gaspar HB; Rigley KP; Brown D; Saeland S; Rousset F; Levinsky RJ; Callard RE; Kinnon C
    Eur J Immunol; 1994 Dec; 24(12):3100-5. PubMed ID: 7805739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK.
    Ng YY; Baert MR; Pike-Overzet K; Rodijk M; Brugman MH; Schambach A; Baum C; Hendriks RW; van Dongen JJ; Staal FJ
    Leukemia; 2010 Sep; 24(9):1617-30. PubMed ID: 20574453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene.
    Maas A; Dingjan GM; Savelkoul HF; Kinnon C; Grosveld F; Hendriks RW
    Eur J Immunol; 1997 Sep; 27(9):2180-7. PubMed ID: 9341757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing.
    de Gorter DJ; Beuling EA; Kersseboom R; Middendorp S; van Gils JM; Hendriks RW; Pals ST; Spaargaren M
    Immunity; 2007 Jan; 26(1):93-104. PubMed ID: 17239630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the tec kinase Bruton's tyrosine kinase (Btk) in leukocyte recruitment.
    Block H; Zarbock A
    Int Rev Immunol; 2012 Apr; 31(2):104-18. PubMed ID: 22449072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 1997 Jan; 2():d27-42. PubMed ID: 9159207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BTK Signaling in B Cell Differentiation and Autoimmunity.
    Corneth OBJ; Klein Wolterink RGJ; Hendriks RW
    Curr Top Microbiol Immunol; 2016; 393():67-105. PubMed ID: 26341110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct gene expression signature in Btk-defective T1 B-cells.
    Lindvall JM; Blomberg KE; Berglöf A; Smith CI
    Biochem Biophys Res Commun; 2006 Jul; 346(2):461-9. PubMed ID: 16764821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predominance of sterile immunoglobulin transcripts in a female phenotypically resembling Bruton's agammaglobulinemia.
    de la Morena M; Haire RN; Ohta Y; Nelson RP; Litman RT; Day NK; Good RA; Litman GW
    Eur J Immunol; 1995 Mar; 25(3):809-15. PubMed ID: 7705412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.
    Whang JA; Chang BY
    Drug Discov Today; 2014 Aug; 19(8):1200-4. PubMed ID: 24721226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency.
    Wood PM; Mayne A; Joyce H; Smith CI; Granoff DM; Kumararatne DS
    J Pediatr; 2001 Jul; 139(1):148-51. PubMed ID: 11445810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1.
    Schubart DB; Rolink A; Schubart K; Matthias P
    J Immunol; 2000 Jan; 164(1):18-22. PubMed ID: 10604987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.